ArticleHaematologica2022

High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline.

Cédric Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.